E
Nirvana Life Sciences Inc. NIRV
CNSX
Recommendation
Sell
Prev Close
$0.005
Volume
--
Avg Vol (90D)
742
Market Cap
$168.80K
Dividend & Yield
--
52-Week Range
$0.005 - $0.08
P/E (TTM)
--
EPS (TTM)
-$0.0069
My Lists My Alerts
Weiss Ratings NIRV - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Rating E
Reward Index Very Weak
Risk Index Weak
Risk Grade D
Reward Grade E
Rating Factors NIRV - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Dividend Index --
Growth Index Fair
Efficiency Index Very Weak
Solvency Index Weak
Total Return Index Weak
Volatility Index Weak
Beta / Standard Deviation NIRV - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Beta -3.52
Price History NIRV - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
7-Day Total Return 500.00%
30-Day Total Return -40.00%
60-Day Total Return -60.00%
90-Day Total Return -60.00%
Year to Date Total Return -40.00%
1-Year Total Return -40.00%
2-Year Total Return -50.00%
3-Year Total Return -95.31%
5-Year Total Return --
52-Week High % Change -93.75%
52-Week Low % Change 0.00%
Price NIRV - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
52-Week High Price $0.08
52-Week Low Price $0.01
52-Week Low Price (Date) Mar 04, 2025
52-Week High Price (Date) Aug 30, 2024
Valuation NIRV - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Market Cap 168.80K
Enterprise Value 232.33K
Price/Earnings (TTM) --
Earnings Per Share (TTM) -0.01
Earnings Per Share Growth -76.53%
Price/Earnings To Growth --
Price/Sales (TTM) --
Price/Book (Q) -0.27
Enterprise Value/Revenue (TTM) --
Price $0.03
Enterprise Value/EBITDA (TTM) -0.65
Enterprise Value/EBIT -0.62
Market Cap Category Nano Cap
Dividends and Shares NIRV - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Shares Outstanding 48.23M
Dividend Yield --
Div. Per Share (Most Recent) --
Dividend Per Share (TTM) --
Payout Ratio (TTM) --
Dividend Per Share (Most Recent) --
Company Info NIRV - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Phone Number 604-401-8100
Address 650 West Georgia Street Vancouver, BC V6B 4N8
Website nirvanalifescience.com
Country Canada
Year Founded --
Profitability NIRV - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Operating Margin (TTM) --
Profit Margin --
Management Effectiveness NIRV - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Return on Assets -227.91%
Return on Equity --
Income Statement NIRV - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Revenue (TTM) --
Total Revenue (TTM) --
Revenue Per Share --
Gross Profit (TTM) --
EBITDA (TTM) -323.20K
EBIT (TTM) -337.30K
Net Income (TTM) -338.00K
Net Income Avl. to Common (TTM) -338.00K
Total Revenue Growth (Q YOY) --
Earnings Growth (Q YOY) 63.88%
EPS Diluted (TTM) -0.01
EPS Diluted Growth (Q YOY) 65.38%
Balance Sheet NIRV - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Cash and Short-Term Inv. (Q) 400.00
Cash Per Share (Q) $0.00
Total Current Assets (Q) 14.00K
Total Preferred Equity (Q) --
Total Equity (Q) -890.80K
Current Ratio (Q) 0.015
Book Value Per Share (Q) -$0.02
Total Assets (Q) 140.50K
Total Current Liabilities (Q) 906.30K
Total Debt (Q) 49.60K
Total Liabilities (Q) 1.03M
Total Common Equity (Q) -886.90K
Cash Flow NIRV - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Cash from Investing (TTM) --
Cash from Financing (TTM) 36.30K
Net Change in Cash (TTM) -7.40K
Levered Free Cash Flow (TTM) 92.20K
Cash from Operations (TTM) -32.40K
Weiss Ratings